PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.753
+0.102 (15.72%)
At close: Mar 6, 2026, 4:00 PM EST
0.755
+0.002 (0.21%)
After-hours: Mar 6, 2026, 7:41 PM EST
PharmaCyte Biotech Employees
PharmaCyte Biotech had 2 employees as of April 30, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,816,659
Market Cap
8.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| Aptevo Therapeutics | 37 |
| Kiora Pharmaceuticals | 12 |
| Alzamend Neuro | 7 |
| Mustang Bio | 6 |
| Quoin Pharmaceuticals | 5 |
| Pulmatrix | 2 |
| Addex Therapeutics | 2 |
PMCB News
- 3 months ago - PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Business Wire
- 6 months ago - PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications - Business Wire
- 7 months ago - PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing - Business Wire
- 7 months ago - PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Business Wire
- 1 year ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 1 year ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 2 years ago - PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc. - Business Wire
- 2 years ago - PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology - Business Wire